search
Back to results

An Exploratory Investigation of the Effects of Single Use vs. Reuse Catheters in Intermittent Catheterization

Primary Purpose

Urinary Incontinence

Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
CLINY catheter
Sponsored by
Coloplast A/S
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Urinary Incontinence

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: ≥18 years of age and has full legal capacity Signed informed consent form Use clean intermittent catheterization to the greatest extent possible (at least three times daily) for at least the last 1 month prior to inclusion Ability (assessed by the investigator) and willingness to participate in a 4-week study period with at least three catheterizations a day using the investigational test product Self-catheterize using a single use hydrophilic coated catheter for at least 1 month prior to inclusion Exclusion Criteria: Participation in any other clinical intervention study during this investigation Previous participation in this investigation Any known allergies towards ingredients in the investigational device Symptoms of UTI at time of inclusion, as judged by the investigator Antibiotic treatment within 2 weeks prior to the Baseline visit (V1) Pregnancy Breastfeeding

Sites / Locations

  • Odense Universitetshospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

CLINY reusable catheter 28 days

Arm Description

The investigation is designed as an open-labelled, single-arm investigation, in which the reuse CLINY catheter will be compared to single use catheters at baseline.

Outcomes

Primary Outcome Measures

Health-related quality of life (HR-QoL) measured by the intermittent self-catheterization questionnaire, (ISC-Q) index score
Subjects will complete the questionnaire at inclusion and termination

Secondary Outcome Measures

Adverse events
Number of Adverse Events during the study

Full Information

First Posted
August 25, 2022
Last Updated
June 16, 2023
Sponsor
Coloplast A/S
search

1. Study Identification

Unique Protocol Identification Number
NCT05626686
Brief Title
An Exploratory Investigation of the Effects of Single Use vs. Reuse Catheters in Intermittent Catheterization
Official Title
An Exploratory Investigation of the Effects of Single Use vs. Reuse Catheters in Intermittent Catheterization
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Completed
Study Start Date
August 12, 2022 (Actual)
Primary Completion Date
March 30, 2023 (Actual)
Study Completion Date
March 30, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Coloplast A/S

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The overall aim of the investigation is to investigate the effect of repeated reuse of intermittent urinary catheters and to observe the impact of switch from single use to multiple reuse catheters.
Detailed Description
Throughout the investigation, the impact of switch from single use to multiple reuse catheters will be observed and compared with respect to health-related quality of life (HR-QoL), satisfaction, perception, and preference in female and male catheter-users, who use clean intermittent catheterization (CIC) for bladder management. Furthermore, the investigation intends to identify microbial contamination of reused catheters and compare proportions to a control single use catheter.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Incontinence

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
The investigation is designed as an open-labelled, single-arm investigation including subjects currently using single use catheters.
Masking
None (Open Label)
Allocation
N/A
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
CLINY reusable catheter 28 days
Arm Type
Experimental
Arm Description
The investigation is designed as an open-labelled, single-arm investigation, in which the reuse CLINY catheter will be compared to single use catheters at baseline.
Intervention Type
Device
Intervention Name(s)
CLINY catheter
Intervention Description
Subjects using a single use catheter for bladder management at inclusion. During the study period, subjects will use the reusable CLINY catheter for 28 test-days
Primary Outcome Measure Information:
Title
Health-related quality of life (HR-QoL) measured by the intermittent self-catheterization questionnaire, (ISC-Q) index score
Description
Subjects will complete the questionnaire at inclusion and termination
Time Frame
28 days
Secondary Outcome Measure Information:
Title
Adverse events
Description
Number of Adverse Events during the study
Time Frame
28 days
Other Pre-specified Outcome Measures:
Title
Intermittent Catheterization Satisfaction (InCaSa) questionnaire score
Description
Subjects will complete the questionnaire at inclusion and termination
Time Frame
28 days
Title
Perception questions (evaluated on a 6-point scale)
Description
Subjects will answer questions at termination
Time Frame
28 days
Title
Total catheter-associated bacterial count (CFU/mL)
Description
Lab assessment on all used catheters during the study
Time Frame
28 days
Title
Number of bacterial-positive catheter samples
Description
Lab assessment on all used catheters during the study
Time Frame
28 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: ≥18 years of age and has full legal capacity Signed informed consent form Use clean intermittent catheterization to the greatest extent possible (at least three times daily) for at least the last 1 month prior to inclusion Ability (assessed by the investigator) and willingness to participate in a 4-week study period with at least three catheterizations a day using the investigational test product Self-catheterize using a single use hydrophilic coated catheter for at least 1 month prior to inclusion Exclusion Criteria: Participation in any other clinical intervention study during this investigation Previous participation in this investigation Any known allergies towards ingredients in the investigational device Symptoms of UTI at time of inclusion, as judged by the investigator Antibiotic treatment within 2 weeks prior to the Baseline visit (V1) Pregnancy Breastfeeding
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karin Andersen
Organizational Affiliation
Odense Universitetshospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Nessn Azawi
Organizational Affiliation
Zealand University Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Brian Kloster
Organizational Affiliation
Ålborg Universitetshospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Odense Universitetshospital
City
Odense
ZIP/Postal Code
5000
Country
Denmark

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

An Exploratory Investigation of the Effects of Single Use vs. Reuse Catheters in Intermittent Catheterization

We'll reach out to this number within 24 hrs